Akari Therapeutics Plc — Form D

Akari Therapeutics Plc of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-28. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (52)

Showing 25 of 52 people.

NameRoleLocation
Mark CohenDirectorBay Harbor Islands, FL
Gur RoshwalbDirectorSan Diego, CA
Allan ShawDirectorResearch Triangle Park, NC
Gur RoshwalbExecutive OfficerSan Diego, CA
James HillDirectorAurora, CO
Dov ElefantDirectorSuwanee, GA
Dov ElefantExecutive OfficerSuwanee, GA
Samir PatelDirectorTAMPA, FL
Samir PatelRelated PersonTAMPA, FL
Sandip PatelDirectorTAMPA, FL
Sandip PatelRelated PersonTAMPA, FL
Ray PrudoDirectorTAMPA, FL
Ray PrudoExecutive OfficerTAMPA, FL
Ray PrudoRelated PersonTAMPA, FL
Hoyoung HuhDirectorTAMPA, FL
Hoyoung HuhRelated PersonTAMPA, FL
Kameel FaragExecutive OfficerTAMPA, FL
Kameel FaragRelated PersonTAMPA, FL
Rob BazemoreDirectorTAMPA, FL
Rob BazemoreRelated PersonTAMPA, FL
Abizer GaslightwalaDirectorTAMPA, FL
Abizer GaslightwalaExecutive OfficerTAMPA, FL
Abizer GaslightwalaRelated PersonTAMPA, FL
Jim NealDirectorTAMPA, FL
Jim NealRelated PersonTAMPA, FL

Other filings by this issuer (13)

FiledFormOfferingSold
2026-06-03D$5.5M$1.8M
2025-10-24D$6.3M$6.3M
2024-01-09D$2.0M$2.0M
2023-10-19D$2.0M$2.0M
2022-09-27D$12.8M$12.8M
2021-07-22D$12.3M$12.3M
2020-03-11D$9.6M$9.6M
2019-07-12D$4.5M$4.5M
2013-09-30D$12.5M$12.5M
2013-02-01D$10.0M$931K
2012-12-13D/A$1.5M$1.5M
2012-12-12D$1.5M$1.5M
2012-04-13D$1.1M

More